Shenwan Lingxin CSI Shenwan Medical Bio-index Grading Fund closely tracks CSI Shenwan Medical Bio-index in the form of complete replication. As a graded fund, the proportion of A shares and B shares in Shenwan Lingxin Zhongzheng Shenwan Pharmaceutical Bio-grading is 1: 1, in which the agreed annualized benchmark return rate of A share is "RMB one-year time deposit benchmark interest rate (after tax) +3%", and B share is a high-risk and high-yield fund share, which can further amplify the index elasticity under the action of double leverage and effectively serve investors.